Next Generation CAR-T Technology Advanced, Clinical Stage CAR-T Platform CoupledCAR for Solid Tumors
创新细胞疗法 我们的使命是开发创新的细胞疗法来改变全球癌症治疗 Innovation Cellular Therapeutics (ICT) 是一家私人临床阶段生物技术公司,总部位于马里兰州罗克维尔。 ICT 专注于开发用于治疗实体瘤的细胞免疫疗法。 ICT 独特的 CoupledCAR® 技术平台旨在克服治疗实体瘤的常见挑战。 ICT 在晚期实体瘤(如结直肠癌和甲状腺癌)中取得了有希望的临床前和概念验证临床结果。 公司拥有广泛的 CAR-T 候选产品线,针对其他实体瘤。 公司里程碑 ICT已发展成为具有世界能力的完全整合的国际CAR-T生物技术公司。 Innovative Cellular Therapeutics Our mission is to develop innovative cellular therapies to transform cancer treatment worldwide Innovative Cellular Therapeutics (ICT) is a private clinical stage biotechnology company headquartered in Rockville, MD. ICT is focused on the development of cellular immunotherapies for the treatment of solid tumors. ICT’s unique CoupledCAR® technology platform is designed to overcome the common challenges of treating solid tumors. ICT has achieved promising preclinical and proof-of-concept clinical results in late-stage solid tumors, such as colorectal cancer and thyroid cancer. The Company has a broad pipeline of CAR-T candidates targeting additional solid tumors. Corporate Milestones ICT has evolved into a fully integrated, international CAR-T biotechnology company with world-class capabilities.